The tyrosine kinase Janus kinase 2 (JAK2) binds to the majority of the known members of the cytokine family of receptors. Ligand-receptor binding leads to activation of the associated JAK2 molecules, resulting in rapid autophosphorylation of multiple tyrosines within JAK2. Phosphotyrosines can then serve as docking sites for downstream JAK2 signaling molecules. Despite the importance of these phosphotyrosines in JAK2 function, only a few sites and binding partners have been identified. Using two-dimensional phosphopeptide mapping and a phosphospecific antibody, we identified tyrosine 813 as a site of JAK2 autophosphorylation of overexpressed JAK2 and endogenous JAK2 activated by growth hormone. Tyrosine 813 is contained within a YXXL sequence motif associated with several other identified JAK2 phosphorylation sites. We show that phosphorylation of tyrosine 813 is required for the SH2 domain-containing adapter protein SH2-B to bind JAK2 and to enhance the activity of JAK2 and STAT5B. The homologous tyrosine in JAK3, tyrosine 785, is autophosphorylated in response to interleukin-2 stimulation and is required for SH2-B to bind JAK3. Taken together these data strongly suggest that tyrosine 813 is a site of autophosphorylation in JAK2 and is the SH2-B-binding site within JAK2 that is required for SH2-B to enhance activation of JAK2.The Janus kinase family of tyrosine kinases (JAK1, JAK2, JAK3, and Tyk2) plays an essential role in the signaling by all members of the cytokine receptor superfamily. The JAKs promote growth, proliferation, and/or differentiation of many cell types (1, 15). Activation of the JAKs occurs upon ligand binding to its receptor. Activation is thought to occur as a consequence of two JAK molecules being brought into close enough proximity to allow for rapid trans-phosphorylation of the activation loop of each kinase (15). The activated JAK molecules then phosphorylate multiple targets, including the JAKs themselves, the associated receptors, and multiple signaling molecules such as the signal transducers and activators of transcription (STATs) (4,10,16,17). Dysregulation of JAKs can lead to a host of physiological problems, including diseases of the immune system (6) and cancer (22,29,40).Among the JAKs, JAK2 is activated by more than two-thirds of the known cytokine receptor ligands, including growth hormone (GH), prolactin, erythropoietin, and leptin, making it the most studied of the JAK family members (14). Autophosphorylation of JAK2 is an important step in regulating signaling as it leads to activation of the kinase. Autophosphorylation also results in the production of potential docking sites for downstream signaling molecules containing phosphotyrosine binding Src homology 2 (SH2) domains, such as the adapter protein, SH2-B, and the JAK2 inhibitor suppressor of cytokine signaling 1 (SOCS-1). Identification of the autophosphorylation sites on JAK2, therefore, is critical for advancing our understanding of how these kinases signal, and could provide potential targets for pharmaceutical ...